cancer research

Chimeric antigen receptor natural killer T (CAR-NKT) cell therapy, a novel form of immunotherapy, is emerging as a promising ‘off-the-shelf’ treatment for patients with pancreatic cancer. In a study published in PNAS, November 21, 2025, U.S. investigators report that CAR-NKT cells…

Where progress is measured not just in science, but in vision, leadership, and care. Every issue of CancerWorld explores people, policies, and practices shaping the future of oncology. In our February issue of CancerWorld, we turn our attention to leadership,…

Each evening, after a day leading one of Italy’s busiest radiotherapy departments, Prof. Andrea Filippi, Head of the Radiation Oncology Unit at the Istituto Nazionale dei Tumori in Milan, and the Associate Professor of Radiation Oncology in the Department of…

If you ask Robert Weinberg how his career began, he will not tell you a story of grand plans or carefully plotted ambition. He will tell you it was “a series of accidents.” “Most people have a series of goals…

Where progress is redesigned with purpose and delivered back to those who need it most Every issue of CancerWorld explores the places where science meets humanity, where personal stories reshape public systems, and where progress in oncology is defined not…

Many people diagnosed with cancer often wonder what “caused” their disease and whether they could have done anything to prevent it. Typically, the risk of developing cancer is determined by a combination of genetics and environmental exposures, causing errors in…

Hello, Dr. Knaul, it’s a great honor to… “Please, call me Felicia,” she interrupted immediately, her warmth cutting through the formality. Felicia Marie Knaul is one of the world’s most influential voices in cancer care advocacy, a leader who doesn’t…

It was an interview during which I simply couldn’t stop smiling, amazed by the brilliance of Prof. Paul Mischel, yet he speaks about his discoveries with such ease, clarity, and enthusiasm that you can’t help but be carried along. Here…

Could artificial sweeteners undo the benefits of immunotherapy? A study published in Cancer Discovery, July 30, found that melanoma and non-small cell lung cancer (NSCLC) patients who consume high levels of the artificial sweetener sucralose have worse responses to immunotherapy…

From Rome to Milan to ESMO’s presidency — a story of science, courage, and mentorship. I am in Yerevan. Giuseppe Curigliano is in Milan, just back from Asia. “JSMO, CSCO, Korea, Japan, China…” he sighs, then laughs. “Too much travel?”…